Supernova 2

Supernova Invest is a Paris-based venture capital firm founded in March 1999, specializing in investing in early-stage to late-stage deep tech startups across various sectors, including healthcare, industrial technologies, energy and environment, and digital technologies. The firm focuses on innovative companies in electronics, advanced materials, and instruments, providing patient capital and expertise to help these businesses scale globally. With a strong portfolio that includes notable companies such as Soitec and ANYbotics, Supernova Invest has successfully exited over 25 companies through significant IPO and M&A transactions. The firm operates from its main office in Paris and a secondary location in Grenoble, France.

Alexandre Biau

Investment Director

Carole Cazassus

Investment Director

Julien Cristiani

Partner

Marine Glon

Investment Director

Celia Hart

Partner

Etienne Moreau

DeepTech Partner

Romain Sautrau

Investment Director

Remi Spagnol

Investment Director

Pierre-Emmanuel Struyven

President and Managing Partner

Michaël Thomas

Partner

Gregoire Viot

CFO

Claude-Sebastien Lerbourg

Investment Director

Pascal-andré Chenal

Investment Director

Past deals in Southern Europe

Diabeloop

Venture Round in 2024
Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

Unseenlabs

Series C in 2024
Unseenlabs is a French company based in Rennes, founded in 2015, that specializes in marine surveillance services utilizing satellite technology. The company develops spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels globally. By launching satellites equipped to detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs can identify vessels even if they disable their Automatic Identification System beacon. This capability allows clients to monitor maritime activities and locate boats engaged in illegal operations, such as illegal fishing, degassing, and maritime piracy. Unseenlabs provides comprehensive solutions that encompass satellite design and launch, ensuring effective maritime monitoring from space.

Vulkam

Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Adionics

Series B in 2023
Adionics is a technology provider based in Paris, France, specializing in saline water treatment and desalination supply chains. Founded in 2012, the company focuses on developing innovative technologies for the selective extraction of salts from brine, seawater, and other salty waters. Its AquaOmnes technology effectively removes salt from water, while Flionex is an ion-absorbing liquid technology designed to bind salts, including lithium. Adionics serves various industries, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes and enable lithium recycling from batteries, aiming to provide efficient and environmentally friendly solutions for extracting valuable minerals.

Aledia

Venture Round in 2023
Aledia SA specializes in the development and manufacturing of innovative light-emitting diodes (LEDs) utilizing a unique 3D architecture based on gallium-nitride-on-silicon microwires. Founded in 2011 and headquartered in Grenoble, France, with additional subsidiaries in Malacca, Malaysia, and Palo Alto, California, Aledia's technology employs standard 8-inch silicon wafers and existing fabrication processes, allowing for the production of LED chips at a significantly reduced cost compared to traditional planar designs. This technology supports a range of applications, including general lighting, automotive, and display technologies, specifically for mobile and microdisplays used in augmented and virtual reality environments. Aledia's focus on efficient, brighter, and cost-effective displays positions it as a key player in the LED market.

Remedee Labs

Series A in 2022
Remedee Labs SAS is a French company founded in 2016, specializing in the research and development of a personal endorphin stimulator aimed at pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a device designed to stimulate the release of the body’s own endorphins on demand. This innovative technology is particularly focused on helping individuals suffering from chronic pain conditions, with an initial emphasis on fibromyalgia. Remedee Labs has developed a patient-centered digital service platform that collaborates with medical practitioners to enhance chronic pain management. Backed by a decade of pre-clinical and clinical research, the company aims to provide a new approach to pain relief for the 1.5 billion people worldwide affected by chronic pain, many of whom are dissatisfied with existing treatment options. In 2019, Remedee Labs secured significant funding from various investors to further its mission of making endorphin-stimulation therapy accessible and effective for personal healthcare.

Prophesee

Series C in 2022
Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

Micropep

Series A in 2022
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.

Micropep

Series A in 2021
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.

Adionics

Seed Round in 2021
Adionics is a technology provider based in Paris, France, specializing in saline water treatment and desalination supply chains. Founded in 2012, the company focuses on developing innovative technologies for the selective extraction of salts from brine, seawater, and other salty waters. Its AquaOmnes technology effectively removes salt from water, while Flionex is an ion-absorbing liquid technology designed to bind salts, including lithium. Adionics serves various industries, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes and enable lithium recycling from batteries, aiming to provide efficient and environmentally friendly solutions for extracting valuable minerals.

Ynsect

Series C in 2020
Ynsect is a biotech company based in Evry, France, specializing in the production and processing of insects for use in animal feed and non-food applications. Founded in 2011, the company operates insect production facilities that utilize bioconversion processes to transform organic resources into high-quality nutrients, including proteins and lipids for livestock and pet nutrition, as well as organic fertilizers and bioenergy. Ynsect's innovative approach allows for large-scale insect farming and automation, making it a preferred partner for agri-food professionals, laboratories, and investors. Through its expertise, Ynsect aims to provide sustainable and premium nutrition solutions, addressing the growing demand for alternative protein sources in the agro-food and environmental biotech sectors.

Microoled

Series A in 2020
Microoled is a French company specializing in the development and manufacturing of microdisplays for mobile near-to-eye viewing devices. Established in 2007 and headquartered in Grenoble, the company focuses on creating AMOLED displays and optical modules that cater to various sectors, including consumer electronics, medical applications, and security. Microoled's product range encompasses video glasses, head-mounted sports devices, and camera viewfinders, among other professional equipment. By addressing customer needs and anticipating market demands, Microoled aims to enhance user experiences across diverse applications.

Vulkam

Series A in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Diabeloop

Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

Remedee Labs

Series A in 2019
Remedee Labs SAS is a French company founded in 2016, specializing in the research and development of a personal endorphin stimulator aimed at pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a device designed to stimulate the release of the body’s own endorphins on demand. This innovative technology is particularly focused on helping individuals suffering from chronic pain conditions, with an initial emphasis on fibromyalgia. Remedee Labs has developed a patient-centered digital service platform that collaborates with medical practitioners to enhance chronic pain management. Backed by a decade of pre-clinical and clinical research, the company aims to provide a new approach to pain relief for the 1.5 billion people worldwide affected by chronic pain, many of whom are dissatisfied with existing treatment options. In 2019, Remedee Labs secured significant funding from various investors to further its mission of making endorphin-stimulation therapy accessible and effective for personal healthcare.

Cailabs

Series B in 2019
Cailabs is a French deep tech company based in Rennes, specializing in the design and production of photonic solutions that optimize the use of light in various applications. The company focuses on light shaping components, including mode multiplexers and converters for fiber optic networks, utilizing its patented Multi-Plane Light Conversion (MPLC) technology to reshape both single-mode and multi-mode coherent beams. Cailabs offers products tailored for telecommunications research and development, as well as multi-mode fiber link upgrades for enterprise networks. Additionally, the company provides integrated solutions for the industrial laser sector, such as laser beam shapers and combiners for material processing, and mode-selective multiplexers for EDFA arrays. Founded in 2013, Cailabs aims to address critical industrial challenges through its innovative optical components and expertise.

Keranova

Venture Round in 2019
Keranova S.A., founded in 2015 and based in Saint Etienne, France, along with an office in Vénissieux, specializes in designing and developing innovative surgical equipment for ophthalmology, specifically targeting the anterior segment of the eye. The company focuses on creating advanced surgical instruments that aim to enhance existing semi-manual, operator-dependent procedures in ophthalmic surgery. Keranova's patented technology allows for a novel approach to anterior segment surgery, utilizing automated equipment equipped with vision, intelligent software, and precise robotic movements. This innovation significantly reduces the need for manual intervention, thereby improving the reproducibility and efficiency of surgical procedures.

NH TherAguix

Series A in 2019
NH TherAguix SAS is a clinical stage pharmaceutical company based in Villeurbanne, France, focused on developing nanomedicines for cancer treatment, specifically utilizing radiotherapy. The company's lead product, AGuIX, is a theranostic nanoparticle designed to enhance the localization of solid tumors and improve the effectiveness of radiation therapy. AGuIX allows for the determination of optimal irradiation timing and is capable of treating radioresistant cancers while minimizing radiation exposure to healthy tissues, thereby reducing secondary effects. Founded in 2015, NH TherAguix is dedicated to advancing innovative solutions in cancer care through its pioneering research and development efforts.

Diota

Series B in 2019
Diota is a provider of Augmented Reality software solutions dedicated to industry. Strong technological innovations along with business-oriented solutions make of the company a key player of the digital factory and industrial competitiveness, notably in the aircraft, railway, shipbuilding, automotive, oil & gas and chemical industries,in France and Europe. Among Diota’s major references are Safran Group, Dassault Aviation, DCNS, SNCF, PSA Group, Renault, Volkswagen, Daimler, Air Liquide, Total, Bouygues Construction…

Prophesee

Series B in 2018
Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

Aledia

Series C in 2018
Aledia SA specializes in the development and manufacturing of innovative light-emitting diodes (LEDs) utilizing a unique 3D architecture based on gallium-nitride-on-silicon microwires. Founded in 2011 and headquartered in Grenoble, France, with additional subsidiaries in Malacca, Malaysia, and Palo Alto, California, Aledia's technology employs standard 8-inch silicon wafers and existing fabrication processes, allowing for the production of LED chips at a significantly reduced cost compared to traditional planar designs. This technology supports a range of applications, including general lighting, automotive, and display technologies, specifically for mobile and microdisplays used in augmented and virtual reality environments. Aledia's focus on efficient, brighter, and cost-effective displays positions it as a key player in the LED market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.